Strain-Dependent Effects of Dietary Cholic Acid on Liver Fibrogenesis and Gut Microbiota in TSNO and TSOD Mice
Authors:
- Taeko AoyamaTATaeko Aoyama
- Nanako IwataNINanako Iwata
- Saki KawamotoSKSaki Kawamoto
- Miyuna KatoMKMiyuna Kato
- Koudai KaniKKKoudai Kani
- Kaichi KasaiKKKaichi Kasai
- Kana GotoKGKana Goto
- Yousei YoshimotoYYYousei Yoshimoto
- Mayuko Ichimura-ShimizuMIMayuko Ichimura-Shimizu
- Shiro WatanabeSWShiro Watanabe
- Koichi TsuneyamaKTKoichi Tsuneyama
- Yukihiro FurusawaYFYukihiro Furusawa
Open Access
- 16 February 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 442
Abstract
Background: Metabolic dysfunction-associated steatohepatitis (MASH) is defined by hepatocellular damage accompanied by inflammation and fibrotic changes. Bile acids (BAs) and gut microbiota play pivotal roles in disease progression. However, the contribution of dietary cholic acid (CA), a primary BA, remains unclear. Methods: We investigated the effect of dietary CA supplementation in Tsumura–Suzuki obese diabetic (TSOD) and Tsumura–Suzuki non-obese (TSNO) mouse strains with distinct metabolic phenotypes. The mice were fed normal diet (ND) or 0.5% CA-supplemented ND. Liver injury, fibrosis, and macrophage dynamics were assessed by biochemical assays, histology, flow cytometry, and RT-qPCR. Gut microbiota composition and fecal BA profiles were analyzed using 16S rRNA sequencing and mass spectrometry. Results: CA supplementation induced hepatomegaly, liver injury, and lipid metabolism abnormalities in both strains. In TSNO mice, CA markedly enhanced hepatic fibrosis, increased Col1a1 and Timp1 expressions, and promoted CD11c+ monocyte-derived macrophage infiltration. In contrast, TSOD mice showed minimal fibrotic responses to CA but exhibited pronounced alterations in gut microbiota composition, including enrichment of Akkermansia muciniphila, along with changes in fecal BA profiles. Flow cytometry further revealed Kupffer cell numbers and increased macrophage recruitment in both strains after CA supplementation. Conclusions: Dietary CA exerts strain-dependent effects on MASH pathogenesis. CA promoted macrophage-driven hepatic fibrosis in TSNO mice, whereas it primarily modulated gut microbiota and BA metabolism in TSOD mice. These findings highlight the dual roles of CA in linking hepatic immune responses with intestinal homeostasis and suggest a context-dependent contribution to MASH progression.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP22K07005)
- Tamura Science and Technology Foundation
This publication has 28 references indexed in Scilit:
- Critical Role of Cholic Acid in the Development of iHFC Diet-induced MASH in TSNO MiceInflammation, 2025
- Impacts of liver macrophages, gut microbiota, and bile acid metabolism on the differences in iHFC diet-induced MASH progression between TSNO and TSOD miceInflammation Research, 2024
- Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of diseaseHepatology, 2017
- Targeting hepatic macrophages to treat liver diseasesJournal of Hepatology, 2017
- Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver diseaseInternational Journal of Obesity, 2017
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host MetabolismCell Metabolism, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Nonalcoholic Fatty Liver DiseaseJAMA, 2015
- TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid LoadingCell Metabolism, 2011
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005